ARKK Holdings of Invitae Corporation (NVTA) - Updated Daily
BioinformaticsGenetic Testing
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 0.18% | $168.17m |
| 🏋🏿♂️Weight Rank In ARKK | 🌏Country |
| 31 | 🇺🇸United States |
| 🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
| 81 | $12.24 |
| 🎫ARK Ownership Percent | |
| 7.07% | |
| Description | |
|---|---|
| invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people. | |
| Website | |
| https://www.invitae.com |
Other ETFs That Hold NVTA
Research Notes and Commentary for NVTA
No Research Notes Found for NVTA